Pharming Group NV (PHAR) — Cash Flow Reinvestment Rate
Pharming Group NV (PHAR) has a Cash Flow Reinvestment Rate of 0.15x as of March 2026, reinvesting $238.86K (capex $238.86K ) from operating cash flow of $1.63 Million. See how much free cash does Pharming Group NV generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharming Group NV Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Pharming Group NV across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Pharming Group NV.
Annual Cash Flow Reinvestment Rate for Pharming Group NV (2017–2025)
Year-by-year capital reinvestment analysis for Pharming Group NV. See financial flexibility index of Pharming Group NV to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.72x | $85.97 Million | $50.07 Million | $751.09K | ▲ +428.3% |
| 2022 | 0.33x | $7.30 Million | $22.46 Million | $1.98 Million | ▼ -40.2% |
| 2021 | 0.54x | $20.59 Million | $37.84 Million | $16.72 Million | ▲ +191.8% |
| 2020 | 0.19x | $15.59 Million | $83.63 Million | $15.30 Million | ▼ -50.6% |
| 2019 | 0.38x | $27.95 Million | $74.15 Million | $25.45 Million | ▲ +155.5% |
| 2018 | 0.15x | $6.81 Million | $46.19 Million | $4.31 Million | ▼ -30.7% |
| 2017 | 0.21x | $9.76 Million | $45.84 Million | $7.25 Million | — |